Clinical Research

The clinical symptoms, quality of life and laboratory indexes of newly diagnosed chronic obstructive pulmonary disease with hypertension

  • Yanqing MAO ,
  • Ya′nan WANG ,
  • Jie. LI
Expand
  • Department of General Medicine,First Affiliated Hospital of Soochow University,Suzhou 215000,China

Received date: 2023-12-26

  Online published: 2024-06-13

Abstract

Objective We tried to investigate the difference of respiratory symptoms, quality of life, blood routine examination and bone metabolism in patients with newly diagnosed chronic obstructive pulmonary disease with and without hypertension. Methods A total of 92 newly diagnosed patients with chronic obstructive pulmonary disease and hypertension treated in our hospital from January 2019 to April 2022 were selected as the observation group, and 92 newly diagnosed patients with COPD without hypertension were selected as the control group. The modified British Medical Research Council Respiratory Questionnaire (mMRC), Chronic Obstructive Pulmonary Disease Self Assessment Test Questionnaire (CAT), Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), SF-36 scale scores, blood routine examination and bone metabolism indexes were different. Results The rate of mMRC grade ≥ 2 and CAT score of the observation group were significantly higher than those of the control group (P < 0.05), while the SF-36 score was significantly lower than that of the control group (P < 0.05). The GOLD grading of the observation group was significantly higher than that of the control group (P < 0.05). The forced vital capacity (FVC) and the first second expiratory volume (FEV1) in the observation group were significantly lower than those in the control group (P < 0.05). There was no significant difference between the observation group and the control group in white blood cell count (WBC), neutrophil count (NEUT) and lymphocyte count (LYM) etc (P > 0.05). The bone mineral density of the femoral neck and blood calcium in the observation group were significantly lower than those in the control group (P < 0.05), while the parathyroid hormone (PTH) and osteocalcin (BGP) were significantly higher than those in the control group (P < 0.05). The levels of C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), IL-4, and IL-10 in the observation group were significantly higher than those in the control group (P < 0.05). The hypertension grade in the observation group was positively correlated with mMRC grade, CAT score and GOLD grade (rs = 0.455, 0.302 and 0.501, P < 0.05), but negatively correlated with FVC and FEV1 (rs = -0.311 and -0.334, P < 0.05). Conclusion The newly diagnosed patients with chronic obstructive pulmonary disease and hypertension have severe respiratory symptoms, poor quality of life, and an increased risk of osteoporosis, and the patient's blood pressure is related to the degree of respiratory symptoms.

Cite this article

Yanqing MAO , Ya′nan WANG , Jie. LI . The clinical symptoms, quality of life and laboratory indexes of newly diagnosed chronic obstructive pulmonary disease with hypertension[J]. The Journal of Practical Medicine, 2024 , 40(11) : 1549 -1553 . DOI: 10.3969/j.issn.1006-5725.2024.11.014

References

1 CHRISTENSON S A, SMITH B M, BAFADHEL M, et al. Chronic obstructive pulmonary disease[J]. Lancet,2022,399(10342):2227-2242. doi:10.1016/s0140-6736(22)00470-6
2 YANG I A, JENKINS C R, SALVI S S. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment[J]. Lancet Respir Med,2022,10(5):497-511. doi:10.1016/s2213-2600(21)00506-3
3 CíFKOVá R. Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview[J]. High Blood Press Cardiovasc Prev,2023,30(4):289-303. doi:10.1007/s40292-023-00582-5
4 HIDAYAT A A, GUNAWAN V A, IRAGAMA F R, et al. Risk Factors and Clinical Characteristics of Acute Kidney Injury in Patients with COVID-19: A Systematic Review and Meta-Analysis[J]. Pathophysiology,2023,30(2):233-247. doi:10.3390/pathophysiology30020020
5 GREULICH T, WEIST B J D, KOCZULLA A R, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population[J]. Respir Med, 2017,132:132-138. doi:10.1016/j.rmed.2017.10.007
6 WANG M T, LIOU J T, LIN C W, et al. Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study[J]. JAMA Intern Med, 2018,178(2):229-238. doi:10.1001/jamainternmed.2017.7720
7 梁振宇, 陈荣昌. 慢性阻塞性肺疾病诊疗指南(2021年修订版)修订历程及思考[J]. 中华结核和呼吸杂志, 2021,44(3):165-166. doi:10.3760/cma.j.cn112147-20210207-00098
8 于超,王英杰,迟相林,等. 2018年版欧洲动脉高血压管理指南与中国高血压防治指南在高血压定义、分类与分层上的几点异同[J]. 中华高血压杂志, 2019,27(9):811-813.
9 范艺龄, 苗青, 廖星,等. 六君子汤联合西医疗法治疗慢性阻塞性肺疾病稳定期的有效性和安全性随机对照试验的系统评价和Meta分析[J]. 中国中药杂志, 2020,45(22):5331-5343.
10 谭漫琳,简文星,梁秋菊,等. 不同评价系统对慢阻肺患者病情及治疗疗效的评估价值[J]. 南方医科大学学报, 2021,41(7):1119-1124. doi:10.12122/j.issn.1673-4254.2021.07.23
11 崔亚楠,陈平,陈燕. 2018年版慢性阻塞性肺疾病全球倡议诊断及处理和预防策略解读[J]. 中华结核和呼吸杂志, 2018,41(3):236-239. doi:10.3760/cma.j.issn.1001-0939.2018.03.019
12 JOELSON A, SIGMUNDSSON F G, KARLSSON J. Responsiveness of the SF-36 general health domain: observations from 14883 spine surgery procedures[J]. Qual Life Res, 2022,31(2):589-596. doi:10.1007/s11136-021-02913-2
13 范晓琳,杨小华,刘月军,等. 2型糖尿病性骨质疏松患者骨小梁分数与骨代谢标志物的相关性分析[J]. 中国骨质疏松杂志, 2021,27(11):1599-1602,1613. doi:10.3969/j.issn.1006-7108.2021.11.008
14 秦川, 艾芬, 付晓幸. 中老年高血压患者使用培哚普利治疗3年对骨密度及骨代谢指标的影响[J]. 中国骨质疏松杂志,2020,26(3):390-393. doi:10.3969/j.issn.1006-7108.2020.03.017
15 徐凤周, 范金鹏, 高开茜,等. 维生素K2联合咪达普利对合并高血压的老年女性骨质疏松患者的疗效观察[J]. 中国骨质疏松杂志, 2021,27(2):269-274. doi:10.3969/j.issn.1006-7108.2021.02.023
16 吴雅琳, 翟建, 胡琴,等. 定量CT骨密度测量应用于血压与腰椎骨密度相关性的研究[J]. 临床放射学杂志, 2020,39(2):382-385.
17 祝凯,李娜,彭朋. 吸气肌耐力训练对高血压患者肺功能、呼吸肌力量及运动能力的影响[J]. 中华物理医学与康复杂志,2021,43(8):707-711. doi:10.3760/cma.j.issn.0254-1424.2021.08.009
18 OLSSON K M, CORTE T J, KAMP J C,et al. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management[J]. Lancet Respir Med, 2023,11(9):820-835. doi:10.1016/s2213-2600(23)00259-x
19 陈凌辉,刘宗军,郜俊清,等. 运动康复对PCI术后患者心肺功能和预后的影响[J]. 临床心血管病杂志, 2022,38(7):577-581.
20 孙以成,林玉芳. 骨愈灵胶囊对绝经后骨质疏松症的疗效及骨代谢指标的影响[J]. 中国骨质疏松杂志, 2020,26(3):416-418,424. doi:10.3969/j.issn.1006-7108.2020.03.023
21 SHOSHTARI F S, BIRANVAND S, REZAEI L, et al. The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure[J]. Int Ophthalmol, 2021,41(5):1763-1771. doi:10.1007/s10792-021-01735-y
22 张炳坤,张喜善. 骨代谢标志物在骨质疏松症诊治中的应用[J]. 中国矫形外科杂志, 2022,30(16):1483-1486.
23 吴春娃,李凯,张翠翠,等. CRP与PCT和SAA对恶性肿瘤化疗后细菌性感染的诊断价值[J]. 中华医院感染学杂志, 2021,31(3):355-359.
24 GUL B, ANWAR R, SALEEM M,et al. Cassia absus-mediated upregulation of IL-4, IL-10 and downregulation of IL-1β, IL-6, TNF- α, NF-κB, IFN-γ in CFA-induced arthritis model[J]. Inflammopharmacology, 2023,31(3):1241-1256. doi:10.1007/s10787-023-01185-1
25 王龙龙,张明,许淑娣,等. COPD患者脑微出血发病率[J]. 中国老年学杂志, 2023,43(5):1074-1077. doi:10.3969/j.issn.1005-9202.2023.05.015
Outlines

/